Skip to main content

Reps to sanction RMAFC boss

Reps to sanction RMAFC boss

The House of Representatives will proceed with the institution of sanctions against acting Chairman and Management of Revenue Mobilisation Allocation and Fiscal Commission (RMAFC), Rep. Mark Gbillah (PDP-Benue) has said.

Gbillah, who is the Chairman of the House ad hoc Committee investigating data collection processes, maintenance and usage in RMAFC made this known at a hearing on Tuesday in Abuja.

The chairman said that the committee was constituted in January, 2018 but had not been unable to finish its work as RMAFC would not comply with the demands of the committee.

Continue reading Reps to sanction RMAFC boss at Vanguard News.


by Urowayino Warami via Vanguard News http://bit.ly/2UVbmWI Best Known Member of the Cabinet Wikipedia

Comments

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...

10-kilometre walk in rememberance of Bruce Mayrock (1949 – 1969)

By Chike Anyaonu I got to know about this name, Bruce Mayrock, some four years ago through Barrister CHUDI Ofodile’s book titled The Politics of Biafra: and The Future Of Nigeria and published by Safari Books Limited, Ibadan in 2016. Ever since then, I have been trying to dig deeper and deeper into the archives to learn more about this young altruistic, dynamic and benevolent personality. An enigma of sorts, for that matter. Ofodile had, in chapter seven of his book, cited Bruce as one of “Biafra’s non- Igbo actors”, those who participated in one way or the other to fight the cause of the ill-fated Republic of Biafra that were not of Igbo origin. One of them who is still alive today is Wole Shoyinka. Though this write up is a kind of joint tribute to all of them, Bruce Mayrock, for me, deserves a special and everlasting mention. He was not an African, but a citizen of the United States of America. So what concerned a 20-year-old university student   in America with what ...